Asklepion Pharmaceuticals
MD - BaltimorePharmaceutical
Focus: Asklepion Pharmaceuticals is a specialty pharma company focused on pediatric and rare disease development, headquartered in Baltimore, MD. The company maintains an active pipeline in neurology and rare diseases with Phase 3-stage assets.
Profile data last refreshed 2d ago · AI intelligence enriched 2w ago
Open Jobs
0
About Asklepion Pharmaceuticals
AI assessmentNot HiringNo open roles listed right now. Follow Asklepion Pharmaceuticals to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Mid-stage
1 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
L-citrulline
Acute Lung InjuryClinical Trials (5)
NCT06989567A Study of Intravenous L-Citrulline in Patients Aged 6-21 Years Old With Sickle Cell Disease Presenting to Emergency Departments in Acute Vaso-Occlusive Crisis
Phase 3Help build intelligence for Asklepion Pharmaceuticals
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.